SC 13G - GAXOS.AI INC. (0001895618) (Subject)

Roseland, NJ, May 21, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced the official launch of UnPGT.ai, a tool that makes text created by generative artificial intelligence sound natural and human. UnGPT introduces a real-time rewriting engine designed to convert machine-generated text into authentic, human-quality content without compromising meaning or context. UnGPT uses a proprietary multi-pass transformation model that outperforms leading AI detection tools and addresses one of the industry's fastest growing concerns: the need for undetectable, high-quality output in se

Roseland, NJ , May 07, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that its product, Gaxos Labs for Game Developers and Publishers, has been officially approved for listing on Amazon Web Services (AWS) Marketplace, one of the cloud industry's largest software distribution platforms.  The approval marks a significant milestone in the Company's go-to-market strategy, enabling seamless deployment of Gaxos Labs by millions of AWS customers across 245 countries and territories. AWS Marketplace listing streamlines procurement for enterprise clients, simplifies software billi

Roseland, NJ, April 08, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced the official launch of the AI-enabled Gaxos Health mobile application for iOS and Android for its customers.  The new AI-driven app is designed to personalize and optimize individual health outcomes through smart technology and science-backed routines. The Gaxos Health app leverages proprietary algorithms to deliver goal-based wellness protocols including nutrition, fitness, supplementation, and behavioral coaching. "We are thrilled to announce the launch of the Gaxos Health app," said Vadim Mats, CEO

Roseland, NJ, March 05, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that the Company has acquired AI technology to bolster its content creation services. This acquisition immediately expands the capabilities of Gaxos Labs and enhances the Company's broader AI development initiatives, setting the stage for growth. This strategic addition equips Gaxos with AI solutions, including advanced text-to-speech (TTS), high-quality image generation, dynamic video assembly, instant narration, enhanced styling, and script automation, unlocking unprecedented possibilities for both u

ROSELAND, NJ, March 04, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc.  (NASDAQ:GXAI) ("the Company"), a company developing artificial intelligence applications across various sectors, today announced that the Company has reincorporated in the State of Nevada from State of Delaware (the "Reincorporation"). The Reincorporation was previously approved by the board of directors of the Company, and subsequently approved by the stockholders of the Company at the Company's Annual Meeting of stockholders held on December 27, 2024. The Company is now subject to the Nevada Revised Statutes. The Reincorporation did not affect any of the Company's contracts with any third parties, and the Company's right

Roseland, NJ, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it will participate in the upcoming Sequire Investor Summit on January 21st – 23rd in San Juan, Puerto Rico. "We are looking forward to participate in the Sequire Summit and sharing what Gaxos has to offer to investors and other participants," said Vadim Mats, CEO of Gaxos. "This is a great opportunity to present our initiatives to an engaged audience as we continue our efforts to create value for shareholders." To meet with Gaxos at the conference, please email [email protected] About The Sequire Inv

Gaxos.ai Inc. raises approximately $9 million in gross proceeds in December 2024 Roseland, NJ, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQ:GXAI), ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of an aggregate of 1,346,669 shares of its common stock at a purchase price of $3.00 per share. In addition, in a concurrent private placement, the Company issued unregistered warrants to purchase up to 1,346,669 shares of common stock. The warrants have an exercise price of $3

Roseland, NJ, Dec. 27, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQ:GXAI), ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,346,669 shares of its common stock at a purchase price of $3.00 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered warrants to purchase up to 1,346,669 shares of common stock. The warrants will have an exercise price of $3.00 per share, will be exercisable upon issuance and expire thr

Roseland, NJ, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that the Company successfully integrated Meshy 4 into their artificial intelligence solution for game developers and publishers, Gaxos Labs. The Meshy 4 update and integration allows artists, designers, and developers to fine-tune mesh topology, limit polycounts, and produce higher-quality 3D models faster and in a more efficient workflow. By utilizing Meshy 4's advanced generative geometry, users can seamlessly toggle between quad- or triangle-based meshes to suit the specific demands of their project.

Roseland, NJ, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQ:GXAI), ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of an aggregate of 1,449,277 shares of its common stock at a purchase price of $3.45 per share. In addition, in a concurrent private placement, the Company issued unregistered warrants to purchase up to 1,449,277 shares of common stock. The warrants have an exercise price of $3.32 per share, are exercisable upon issuance and expire three years following the d

Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell. "The addition of top medical talent to our Medical Advisory Board reflects our continued commitment to pursuing a best-in-class solution for Gaxos Health," said Vadim Mats, CEO of Gaxos.AI. "An advisory board of experts in their respective fields will allow to create a better product and advancing our mission of creating value for shareholders." Dr. Eric Margolis, M.D.  is a Board-Ce

4 - GAXOS.AI INC. (0001895618) (Issuer)

4 - GAXOS.AI INC. (0001895618) (Issuer)

4 - GAXOS.AI INC. (0001895618) (Issuer)

3 - GAXOS.AI INC. (0001895618) (Issuer)

4 - GAXOS.AI INC. (0001895618) (Issuer)

4 - GAXOS.AI INC. (0001895618) (Issuer)

4 - GAXOS.AI INC. (0001895618) (Issuer)

Roseland, NJ, March 13, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it had acquired the rights to use certain AI-enabled technology from a top biohacking app, "Ultiself," in order to facilitate the development of its tech for Gaxos Health. The integration of Ultiself's proprietary technology into Gaxos Health's proposed product offering will enable enhanced customization and user experience aligning with modern-day consumer's demands for custom and efficient solutions. This move is expected to accelerate Gaxos Health's development and help solidify its positio

10-Q - GAXOS.AI INC. (0001895618) (Filer)

10-K - GAXOS.AI INC. (0001895618) (Filer)

8-K12B - GAXOS.AI INC. (0001895618) (Filer)

8-K - GAXOS.AI INC. (0001895618) (Filer)

424B3 - GAXOS.AI INC. (0001895618) (Filer)

EFFECT - GAXOS.AI INC. (0001895618) (Filer)

SCHEDULE 13G/A - GAXOS.AI INC. (0001895618) (Subject)

S-1/A - GAXOS.AI INC. (0001895618) (Filer)

S-1 - GAXOS.AI INC. (0001895618) (Filer)

SCHEDULE 13G - GAXOS.AI INC. (0001895618) (Subject)